✦ LIBER ✦

Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double-Blind, Responder-Selected Study Evaluating Monotherapy

✍ Scribed by Elinor Ben-Menachem; Ursula Falter

Book ID: 109108401
Publisher: Wiley (Blackwell Publishing)
Year: 2000
Tongue: English
Weight: 667 KB
Volume: 41
Category: Article
ISSN: 0013-9580
DOI: 10.1111/j.1528-1157.2000.tb04605.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Levetiracetam (up

Efficacy and Safety of Levetiracetam (up to 2000 mg/day) in Taiwanese Patients with Refractory Partial Seizures: A Multicenter, Randomized, Double-blind, Placebo-controlled Study

✍ Jing-Jane Tsai; Der-Jen Yen; Mo-Song Hsih; Shung-Sheng Chen; Reinhard Hiersemenz 📂 Article 📅 2006 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 168 KB

Multicenter Double-Blind, Randomized, Pl

Multicenter Double-Blind, Randomized, Placebo-Controlled Trial of Levetiracetam as Add-On Therapy in Patients with Refractory Partial Seizures

✍ Simon D. Shorvon; Armand Löwenthal; Dieter Janz; Edith Bielen; Pierre Loiseau; f 📂 Article 📅 2000 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 672 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures

✍ Jonathan J. Halford; Elinor Ben-Menachem; Patrick Kwan; Seth Ness; Jennifer Schm 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 459 KB

A multicenter, randomized, double-blind

A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

✍ Daniel L. Rubin; Terry S. Desser; Richard Semelka; Jeffrey Brown; Hanh V. Nghiem 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 3 views